首页 / 院系成果 / 成果详情页

Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis.

  • 编号:
    4CA8771F3FE31EC9E1145BCF42F740C2
  • 作者:
    Wang LinLin(王琳琳)#[1] Wang Ye[2] Cheng Xianbin[3] Li Xingzhao[1] Li Jun(李军)[4]
  • 地址:

    [1]Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.

    [2]Department of Pediatrics, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.

    [3]Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.

    [4]Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.

  • 语种:
    英文
  • 期刊:
    Translational oncology ISSN:1936-5233 2023 年 28 卷 (101605 - ) ; 2023-Feb
  • 收录:
  • 关键词:
  • 摘要:

    The coronavirus disease 2019 (COVID-19) pandemic poses a great challenge to the treatment of lung cancer patients.;The PubMed, Embase, and Web of Science databases were searched for studies published before March 15, 2022, and Stata 14.0 software was used to perform a meta-analysis with a random-effects model. The odds ratio (OR) along with the corresponding 95% confidence interval (CI) was reported.;Our meta-analysis included 80 articles with 318,352 patients involved. The proportion of lung cancer patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was 2.4% (95% CI: 0.02-0.03) prior to the Omicron variant outbreak. Among COVID-19 patients, those with lung cancer showed a higher mortality rate than those with other types of malignant solid tumors (OR = 1.82, 95% CI: 1.61-2.06) and non-cancer patients (OR = 4.67, 95% CI: 3.61-6.05); however, no significant difference was observed in the mortality rate between patients with lung cancer and those with hematologic malignancies (OR = 1.07, 95% CI: 0.85-1.33). SARS-CoV-2 infection significantly increased the mortality rate in lung cancer patients (OR = 8.94, 95% CI: 6.50-12.31). By contrast, the all-cause mortality rate in lung cancer patients (OR = 1.04, 95% CI: 0.69-1.57) and the proportion of patients diagnosed with advanced lung cancer (OR = 1.04, 95% CI: 0.85-1.27) did not significantly change before and after the pandemic.;More attention should be paid on improving the health of lung cancer patients during the COVID-19 pandemic.;

  • 推荐引用方式
    GB/T 7714:
    Wang Linlin,Wang Ye,Cheng Xianbin, et al. Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis. [J].Translational oncology,2023,28:101605-.
  • APA:
    Wang Linlin,Wang Ye,Cheng Xianbin,Li Xingzhao,&Li Jun.(2023).Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis. .Translational oncology,28:101605-.
  • MLA:
    Wang Linlin, et al. "Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis." .Translational oncology 28(2023):101605-.
浏览次数:17 下载次数:0
浏览次数:17
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部